Johns Hopkins ABX Guide
Grepafloxacin
INDICATIONS
FDA
FDA
- No longer manufactured for U.S. or global markets due to QTc prolongation; withdrawn in the U.S. in 1999 (due to cardiac events and sudden death)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Acute exacerbation of chronic bronchitis
- Chlamydial infection
- Community-acquired pneumonia
- Gonorrhea
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: November 10, 2024
Citation
Auwaerter, Paul G, and Edina Avdic. "Grepafloxacin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2024. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540250/all/Grepafloxacin.
Auwaerter PG, Avdic E. Grepafloxacin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2024. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540250/all/Grepafloxacin. Accessed January 22, 2025.
Auwaerter, P. G., & Avdic, E. (2024). Grepafloxacin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540250/all/Grepafloxacin
Auwaerter PG, Avdic E. Grepafloxacin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2024. [cited 2025 January 22]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540250/all/Grepafloxacin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Grepafloxacin
ID - 540250
A1 - Auwaerter,Paul,M.D.
AU - Avdic,Edina,Pharm.D.
Y1 - 2024/11/10/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540250/all/Grepafloxacin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
